Free Trial

Geode Capital Management LLC Sells 2,792,187 Shares of MultiPlan Co. (NYSE:MPLN)

MultiPlan logo with Medical background

Geode Capital Management LLC cut its holdings in shares of MultiPlan Co. (NYSE:MPLN - Free Report) by 98.0% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 57,661 shares of the company's stock after selling 2,792,187 shares during the quarter. Geode Capital Management LLC owned approximately 0.36% of MultiPlan worth $441,000 as of its most recent SEC filing.

A number of other large investors also recently added to or reduced their stakes in MPLN. Millennium Management LLC lifted its position in shares of MultiPlan by 3,401.0% in the second quarter. Millennium Management LLC now owns 8,426,081 shares of the company's stock worth $3,273,000 after buying an additional 8,185,402 shares in the last quarter. AQR Capital Management LLC raised its holdings in shares of MultiPlan by 386.2% during the 2nd quarter. AQR Capital Management LLC now owns 2,742,735 shares of the company's stock worth $1,065,000 after acquiring an additional 2,178,590 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. bought a new position in shares of MultiPlan during the 2nd quarter valued at approximately $245,000. Hsbc Holdings PLC grew its holdings in shares of MultiPlan by 68.7% in the second quarter. Hsbc Holdings PLC now owns 218,459 shares of the company's stock valued at $87,000 after purchasing an additional 88,944 shares in the last quarter. Finally, Cubist Systematic Strategies LLC bought a new stake in MultiPlan in the second quarter worth $72,000. 87.15% of the stock is owned by hedge funds and other institutional investors.

MultiPlan Trading Up 3.2 %

Shares of NYSE:MPLN opened at $12.77 on Monday. MultiPlan Co. has a 12 month low of $4.80 and a 12 month high of $53.60. The firm's 50-day moving average price is $9.00. The company has a market cap of $206.50 million, a P/E ratio of -0.13 and a beta of 0.10. The company has a debt-to-equity ratio of 21.73, a current ratio of 1.05 and a quick ratio of 1.05.

Analyst Upgrades and Downgrades

Separately, Citigroup upped their target price on shares of MultiPlan from $10.00 to $12.50 and gave the company a "neutral" rating in a research report on Friday.

Check Out Our Latest Stock Analysis on MultiPlan

MultiPlan Company Profile

(Free Report)

MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services.

Recommended Stories

Institutional Ownership by Quarter for MultiPlan (NYSE:MPLN)

Should You Invest $1,000 in MultiPlan Right Now?

Before you consider MultiPlan, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MultiPlan wasn't on the list.

While MultiPlan currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Why the Latest Jobs Data Has Wall Street Nervous
7 Large-Cap Stocks Headed for Strong, Steady Gains in 2025
3 Stocks Insiders Are Selling, But Analysts Still Love

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines